Molecular pathogenesis of Parkinson's disease
10.1093/hmg/ddi308
Crossref journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
Bibliography

Gandhi, S., & Wood, N. W. (2005). Molecular pathogenesis of Parkinson’s disease. Human Molecular Genetics, 14(18), 2749–2755.

Authors 2
  1. Sonia Gandhi (first)
  2. Nicholas W. Wood (additional)
References 59 Referenced 162
  1. Parkinson, J. ( 1817 ) An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci. Spring , 14 , 223 –236; discussion 222. (10.1176/jnp.14.2.223)
  2. Braak, H., Del Tredici, K., Rub, U., de Vos, R.A., Jansen Steur, E.N. and Braak, E. ( 2003 ). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging , 24 , 197 –211. (10.1016/S0197-4580(02)00065-9)
  3. Seniuk, N.A., Tatton, W.G. and Greenwood, C.E. ( 1990 ). Dose-dependent destruction of the coeruleus–cortical and nigral–striatal projections by MPTP. Brain Res. , 527 , 7 –20. (10.1016/0006-8993(90)91055-L)
  4. Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. and Di Monte, D.A. ( 2002 ). The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. , 277 , 1641 –1644. (10.1074/jbc.C100560200)
  5. Forno, L.S., Langston, J.W., DeLanney, L.E., Irwin, I. and Ricaurte, G.A. ( 1986 ). Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann. Neurol. , 20 , 449 –455. (10.1002/ana.410200403)
  6. Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T. ( 2000 ). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. , 3 , 1301 –1306. (10.1038/81834)
  7. Fornai, F., Schluter, O.M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C.L., Pontarelli, F., Battaglia, G. et al. ( 2005 ) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin–proteasome system and alpha-synuclein. Proc. Natl Acad. Sci. USA , 102 , 3413 –3418. (10.1073/pnas.0409713102)
  8. Andersen, J.K. ( 2004 ) Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. , 10 (suppl.), S18 –S25. (10.1038/nrn1434)
  9. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P. and Marsden, C.D. ( 1994 ) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. , 36 , 348 –355. (10.1002/ana.410360305)
  10. Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. and Marsden, C.D. ( 1990 ) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. , 54 , 823 –827. (10.1111/j.1471-4159.1990.tb02325.x)
  11. Parker, Jr W.D., Boyson, S.J. and Parks, J.K. ( 1989 ) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. , 26 , 719 –723. (10.1002/ana.410260606)
  12. Bonifati, V., Rizzu, P., Van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. ( 2002 ). Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science , 299 , 256 –259. (10.1126/science.1077209)
  13. Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. ( 2004 ) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA , 101 , 9103 –9108. (10.1073/pnas.0402959101)
  14. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M, Takahashi, K. and Ariga, H. ( 2004 ) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. , 5 , 213 –218. (10.1038/sj.embor.7400074)
  15. Zhang, L., Shimoji, M., Thomas, B., Moore, D.J., Yu, S.W., Marupudi, N.I., Torp, R., Torgner, I.A., Ottersen, O.P., Dawson, T.M., Dawson, V.L. ( 2005 ) Mitochondrial localization of the Parkinson's disease related protein DJ‐1: implications for pathogenesis. Hum. Mol. Genet. , 14 , 2063 –2073. (10.1093/hmg/ddi211)
  16. Jin, J., Meredith, G.E., Chen, L., Zhou, Y., Xu, J., Shie, F.S., Lockhart, P. and Zhang, J. ( 2005 ) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. , 134 , 119 –138. (10.1016/j.molbrainres.2004.10.003)
  17. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. ( 2004 ) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science , 304 , 1158 –1160. (10.1126/science.1096284)
  18. Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D.W., Petsko, G.A. and Cookson, M.R. ( 2005 ) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA , 102 , 5703 –5708. (10.1073/pnas.0500617102)
  19. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. ( 1997 ). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science , 276 , 2045 –2047. (10.1126/science.276.5321.2045)
  20. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. ( 1998 ). α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA , 95 , 6469 –6473. (10.1073/pnas.95.11.6469)
  21. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. ( 2003 ) Alpha-synuclein locus triplication causes Parkinson's disease. Science , 302 , 841 . (10.1126/science.1090278)
  22. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. et al. ( 2004 ) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. , 55 , 164 –173. (10.1002/ana.10795)
  23. Gwinn-Hardy, K., Mehta, N.D., Farrer, M., Maraganore, D., Muenter, M., Yen, S.H., Hardy, J. and Dickson, D.W. ( 2000 ) Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol. (Berl.) , 99 , 663 –672. (10.1007/s004010051177)
  24. Giasson, B.I., Murray, I.V., Trojanowski, J.Q. and Lee, V.M. ( 2001 ) A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. , 276 , 2380 –2386. (10.1074/jbc.M008919200)
  25. Conway, K.A., Lee, S.J., Rochet, J.C., Ding, T.T., Williamson, R.E. and Lansbury, P.T. Jr. ( 2000 ). Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA , 97 , 571 –576. (10.1073/pnas.97.2.571)
  26. Giasson, B.I., Duda, J.E., Murray, I.V., Chen, Q., Souza, J.M., Hurtig, H.I., Ischiropoulos, H., Trojanowski, J.Q. and Lee, V.M. ( 2000 ) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science , 290 , 985 –989. (10.1126/science.290.5493.985)
  27. Conway, K.A., Rochet, J.C., Bieganski, R.M. and Lansbury, P.T. Jr. ( 2001 ) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine–alpha-synuclein adduct. Science , 294 , 1346 –1349. (10.1126/science.1063522)
  28. Matsuoka, Y., Vila, M., Lincoln, S., McCormack, A., Picciano, M., LaFrancois, J., Yu, X., Dickson, D., Langston, J.W., McGowan, E. et al. ( 2001 ) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. , 8 , 535 –539. (10.1006/nbdi.2001.0392)
  29. Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T.E., Muzyczka, N., Mandel, R.J. and Bjorklund, A. ( 2002 ). Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci. , 22 , 2780 –2791. (10.1523/JNEUROSCI.22-07-02780.2002)
  30. Feany, M.B. and Bender, W.W. ( 2000 ). A Drosophila model of Parkinson's disease. Nature , 404 , 394 –398. (10.1038/35006074)
  31. Chen, L. and Feany, M.B. ( 2005 ) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. , 8 , 657 –663. (10.1038/nn1443)
  32. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. ( 1998 ). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature , 392 , 605 –608. (10.1038/33416)
  33. Mata, I.F., Lockhart, P.J. and Farrer, M.J. ( 2004 ) Parkin genetics: one model for Parkinson's disease. Hum. Mol. Genet. , 13 , R127 –R133. (10.1093/hmg/ddh089)
  34. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K, Chiba, T., Tanaka, K. and Suzuki, T. ( 2000 ) Familial Parkinson disease gene product, parkin, is a ubiquitin–protein ligase. Nat. Genet. , 25 , 302 –305. (10.1038/77060)
  35. Cookson, M.R. ( 2005 ) The biochemistry of Parkinson's disease. Annu. Rev. Biochem. , 74 , 29 –52. (10.1146/annurev.biochem.74.082803.133400)
  36. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. and Lu, B. ( 2003 ) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron , 37 , 911 –924. (10.1016/S0896-6273(03)00143-0)
  37. Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J. et al. ( 2003 ) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. , 278 , 43628 –43635. (10.1074/jbc.M308947200)
  38. Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B. and Pallanck, L.J. ( 2003 ) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA , 100 , 4078 –4083. (10.1073/pnas.0737556100)
  39. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. et al. ( 1998 ) The ubiquitin pathway in Parkinson's disease. Nature , 395 , 451 –452. (10.1038/26652)
  40. Saigoh, K., Wang, Y.L., Suh, J.G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T. and Wada, K. ( 1999 ) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. , 23 , 47 –51. (10.1038/12647)
  41. Chung, K.K., Dawson, V.L. and Dawson, T.M. ( 2001 ) The role of the ubiquitin–proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. , 24 (Suppl. 11), S7 –S14. (10.1016/S0166-2236(00)01998-6)
  42. McNaught, K.S., Perl, D.P., Brownell, A.L. and Olanow, C.W. ( 2004 ) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. , 56 , 149 –162. (10.1002/ana.20186)
  43. Unoki, M. and Nakamura, Y. ( 2001 ) Growth-suppressive effects of BPOZ and EGR2 , two genes involved in the PTEN signaling pathway. Oncogene , 20 , 4457 –4465. (10.1038/sj.onc.1204608)
  44. MacKeigan, J.P., Murphy, L.O. and Blenis, J. ( 2005 ) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. , 7 , 591 –600. (10.1038/ncb1258)
  45. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. ( 2004 ) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron , 44 , 595 –600. (10.1016/j.neuron.2004.10.023)
  46. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. ( 2004 ) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron , 44 , 601 –607. (10.1016/j.neuron.2004.11.005)
  47. Shen, J. ( 2004 ) Protein kinases linked to the pathogenesis of Parkinson's disease. Neuron , 44 , 575 –577. (10.1016/j.neuron.2004.11.008)
  48. Hoglinger, G.U., Carrard, G., Michel, P.P., Medja, F., Lombes, A., Ruberg, M., Friguet, B. and Hirsch, E.C. ( 2003 ) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem. , 86 , 1297 –1307. (10.1046/j.1471-4159.2003.01952.x)
  49. Sullivan, P.G., Dragicevic, N.B., Deng, J.H., Bai, Y., Dimayuga, E., Ding, Q., Chen, Q., Bruce-Keller, A.J. and Keller, J.N. ( 2004 ) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. , 279 , 20699 –20707. (10.1074/jbc.M313579200)
  50. Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. ( 2004 ) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. , 279 , 18614 –18622. (10.1074/jbc.M401135200)
  51. Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. and Di Monte, D.A. ( 2002 ) The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. , 277 , 1641 –1644. (10.1074/jbc.C100560200)
  52. Dauer, W., Kholodilov, N., Vila, M., Trillat, A.C., Goodchild, R., Larsen, K.E., Staal, R., Tieu, K., Schmitz, Y., Yuan, C.A. et al. ( 2002 ) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl Acad. Sci. USA , 99 , 14524 –14529. (10.1073/pnas.172514599)
  53. Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A. and Wolozin, B. ( 2003 ) Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J. Biol. Chem. , 278 , 11753 –11759. (10.1074/jbc.M208641200)
  54. Lindersson, E., Beedholm, R., Hojrup, P., Moos, T., Gai, W., Hendil, K.B. and Jensen, P.H. ( 2004 ) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem. , 279 , 12924 –12934. (10.1074/jbc.M306390200)
  55. Autere, J., Moilanen, J.S., Finnila, S., Soininen, H., Mannermaa, A., Hartikainen, P., Hallikainen, M. and Majamaa, K. ( 2004 ) Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia. Hum. Genet. , 115 , 29 –35. (10.1007/s00439-004-1123-9)
  56. Singleton, A., Myers, A. and Hardy, J. ( 2004 ) The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum. Mol. Genet. , 13 , R123 –R126. (10.1093/hmg/ddh093)
  57. Gilks, W.P., Abou-Sleiman, P.M., Gandhi, S., Jain, S., Singleton, A., Lees, A.J., Shaw, K., Bhatia, K.P., Bonifati, V., Quinn, N.P. et al. ( 2005 ) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet , 365 , 415 –416. (10.1016/S0140-6736(05)17830-1)
  58. Di Fonzo, A., Rohe, C.F., Ferreira, J., Chien, H.F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N. et al. ( 2005 ) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet , 365 , 412 –415. (10.1016/S0140-6736(05)17829-5)
  59. Nichols, W.C., Pankratz, N., Hernandez, D., Paisan-Ruiz, C., Jain, S., Halter, C.A., Michaels, V.E., Reed, T., Rudolph, A., Shults, C.W. et al. ( 2005 ) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet , 365 , 410 –412. (10.1016/S0140-6736(05)17828-3)
Dates
Type When
Created 20 years ago (Aug. 26, 2005, 8:13 p.m.)
Deposited 5 years, 4 months ago (April 9, 2020, 2:59 a.m.)
Indexed 2 months ago (July 2, 2025, 4:30 a.m.)
Issued 20 years ago (Aug. 26, 2005)
Published 20 years ago (Aug. 26, 2005)
Published Online 20 years ago (Aug. 26, 2005)
Published Print 19 years, 11 months ago (Sept. 15, 2005)
Funders 0

None

@article{Gandhi_2005, title={Molecular pathogenesis of Parkinson’s disease}, volume={14}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddi308}, DOI={10.1093/hmg/ddi308}, number={18}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Gandhi, Sonia and Wood, Nicholas W.}, year={2005}, month=aug, pages={2749–2755} }